Details of the Drug

General Information of Drug (ID: DMZ5I80)

Drug Name
CP-613
Indication
Disease Entry ICD 11 Status REF
Pancreatic cancer 2C10 Phase 2 [1]
Cross-matching ID
TTD ID
D07FXF

References

1 Clinical pipeline report, company report or official report of Cornerstone pharmaceuticals.